A rapid nanobody based approach for developing antimicrobials against drug- resistant bacteria and yeasts
Sanjiban Banerjee
This paper describes the development of a platform technology for a new class of antimicrobial biologicals called AbTids to target drug resistant bacteria using pathogen specific camelid antibodies and antimicrobial peptide conjugates.